Related Experiment Videos
Developmental differences in acute nigrostriatal and mesocorticolimbic system response to haloperidol
M H Teicher1, N I Barber, H A Gelbard
1Department of Psychiatry, McLean Hospital, Belmont, MA 02178.
Summary
Young rats show heightened sensitivity to haloperidol, a dopamine-blocking drug, affecting brain chemical levels differently with age. These developmental changes in brain response are linked to behavioral differences.
Area of Science:
- Neuroscience
- Pharmacology
- Developmental Biology
Background:
- Haloperidol is an antipsychotic drug that affects dopamine pathways.
- Brain development influences drug response and neurotransmitter system maturation.
Purpose of the Study:
- To investigate the dose-dependent effects of haloperidol on dopamine metabolites in developing rats.
- To compare the sensitivity and response to haloperidol across different brain regions and ages.
Main Methods:
- Administered varying doses of haloperidol (IP) to rats of different ages (18, 30, 110 days).
- Measured levels of dopamine, homovanillic acid (HVA), and dihydroxyphenylacetic acid (DOPAC) in the corpus striatum, nucleus accumbens, and medial prefrontal cortex (PFCTX).
Main Results:
- Younger rats (18-day-old) exhibited greater sensitivity to haloperidol's effects on dopamine turnover in the striatum and nucleus accumbens compared to adults.
- Haloperidol produced comparable increases in DOPAC levels across all ages and brain regions at maximal doses.
- With maturation, the increase in HVA levels relative to DOPAC response became more pronounced in the nucleus accumbens and striatum.
Conclusions:
- Significant developmental variations exist in brain region sensitivity and response to haloperidol.
- These neurochemical findings correlate with previously observed developmental differences in behavioral sensitivity to haloperidol.